138 related articles for article (PubMed ID: 31531759)
1. Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7.
Di Stasi R; Diana D; De Rosa L; Fattorusso R; D'Andrea LD
Mol Biotechnol; 2019 Nov; 61(11):860-872. PubMed ID: 31531759
[TBL] [Abstract][Full Text] [Related]
2. VEGFR1(D2) in drug discovery: Expression and molecular characterization.
Di Stasi R; Diana D; Capasso D; Palumbo R; Romanelli A; Pedone C; Fattorusso R; D'Andrea LD
Biopolymers; 2010; 94(6):800-9. PubMed ID: 20564033
[TBL] [Abstract][Full Text] [Related]
3. Human Recombinant VEGFR2D4 Biochemical Characterization to Investigate Novel Anti-VEGFR2D4 Antibodies for Allosteric Targeting of VEGFR2.
Di Stasi R; De Rosa L; Diana D; Fattorusso R; D'Andrea LD
Mol Biotechnol; 2019 Jul; 61(7):513-520. PubMed ID: 31025286
[TBL] [Abstract][Full Text] [Related]
4. Soluble Expression and Purification of the Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor 2 in Escherichia coli.
Wei J; Cao X; Zhou S; Chen C; Yu H; Zhou Y; Wang P
J Microbiol Biotechnol; 2015 Aug; 25(8):1227-33. PubMed ID: 25907066
[TBL] [Abstract][Full Text] [Related]
5. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
Shibuya M
J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling.
Thieltges KM; Avramovic D; Piscitelli CL; Markovic-Mueller S; Binz HK; Ballmer-Hofer K
Angiogenesis; 2018 Aug; 21(3):533-543. PubMed ID: 29502220
[TBL] [Abstract][Full Text] [Related]
8. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells.
Zhang S; Gao X; Fu W; Li S; Yue L
Breast Cancer Res Treat; 2017 Jun; 163(3):423-434. PubMed ID: 28303365
[TBL] [Abstract][Full Text] [Related]
10. Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.
Hyde CA; Giese A; Stuttfeld E; Abram Saliba J; Villemagne D; Schleier T; Binz HK; Ballmer-Hofer K
Mol Cell Biol; 2012 Oct; 32(19):3802-13. PubMed ID: 22801374
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent resonance energy transfer imaging of VEGFR dimerization.
Ahmadova Z; Yagublu V; Förg T; Hajiyeva Y; Jesenofsky R; Hafner M; Keese M
Anticancer Res; 2014 May; 34(5):2123-33. PubMed ID: 24778014
[TBL] [Abstract][Full Text] [Related]
12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
13. Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.
Zhang J; Li H; Chen W; Cao P; Wang M
Biotechnol Prog; 2009; 25(6):1703-8. PubMed ID: 19731341
[TBL] [Abstract][Full Text] [Related]
14. Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
Holzer TR; Fulford AD; Reising LO; Nedderman DM; Zhang X; Benjamin LE; Schade AE; Nasir A
Anticancer Res; 2016 Jul; 36(7):3277-88. PubMed ID: 27354584
[TBL] [Abstract][Full Text] [Related]
15. [Prokaryotic expression, purification and identification of VEGFR2 D3.4/GST fusion protein in E.coli].
Wei YY; Song CJ; Sun YJ; Gong JY; Jin BQ; Yang AG; Yang K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):870-2. PubMed ID: 18782519
[TBL] [Abstract][Full Text] [Related]
16. Suppression of angiogenesis and tumor growth by recombinant T4 phages displaying extracellular domain of vascular endothelial growth factor receptor 2.
Zuo S; Dai G; Wang L; Wen Y; Huang Z; Yang W; Ma W; Ren X
Arch Virol; 2019 Jan; 164(1):69-82. PubMed ID: 30259141
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers.
Dosch DD; Ballmer-Hofer K
FASEB J; 2010 Jan; 24(1):32-8. PubMed ID: 19726758
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors.
Perez-Moral N; Needs PW; Moyle CWA; Kroon PA
Molecules; 2019 Jul; 24(15):. PubMed ID: 31370204
[TBL] [Abstract][Full Text] [Related]
19. Cooperative interactions between VEGFR2 extracellular Ig-like subdomains ensure VEGFR2 dimerization.
King C; Wirth D; Workman S; Hristova K
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2559-2567. PubMed ID: 28847506
[TBL] [Abstract][Full Text] [Related]
20. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
Li H; Cao W; Chen Z; Acheampong DO; Jin H; Li D; Zhang J; Wang M
Biomed Pharmacother; 2013 Sep; 67(7):599-606. PubMed ID: 23906761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
